Papers for

genetic testing companies

Papers whose findings have a practical use for this group, as judged from the abstract. Open a paper to read what it means in practice.

HPOQuest improves rare disease diagnosis by asking smart questions

HPOQuest: A Rare-Disease Diagnostic Agent Using Active Phenotype Acquisition

Abstract: More than 300 million people worldwide are affected by one of over 7,000 known rare diseases, yet diagnosis remains difficult because patients initially present with incomplete and heterogeneous phenotypes. We present HPOQuest, a training-free framework for sequential phenotype acquisition in rare-disease diagnosis. Starting from a small set of observed patient phenotypes, HPOQuest maintains a probabilistic disease ranking and iteratively selects informative follow-up questions to support clinicians during patient assessment. Confirmed phenotypes update the disease ranking, while all responses update the candidate question set. Across four benchmark cohorts, HPOQuest substantially improves diagnosis from sparse initial phenotypes, with gains of up to 30% points at Recall@1 and 45% points at Recall@5. These results demonstrate that sequential phenotype acquisition can substantially improve rare-disease diagnosis from limited initial clinical evidence.

Wed 16 SeptArtificial IntelligenceMachine Learning
The gist
Diagnosing rare diseases is hard because patients often show only some symptoms at first. The authors created HPOQuest, a tool that starts with a few known symptoms and then asks doctors the most useful follow-up questions to learn more. Each new symptom helps refine which diseases are most likely, making diagnosis more accurate. Tests showed HPOQuest can greatly improve diagnosis accuracy even when starting with limited information.
Open → 2609.18431v1